MedTrace Logo

A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients

NCT01202084 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2015-06-18

No results posted yet for this study

Summary

The primary objective will be to compare the impact of the study formulations on pulmonary function in persistent asthma carriers.

Conditions

Interventions

DRUG

Formoterol/Fluticasone

DRUG

Foraseq®

DRUG

Fluticasone

Sponsors & Collaborators

  • Eurofarma Laboratorios S.A.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01202084 on ClinicalTrials.gov